# Zosyn in Galaxy Containers

NDC: 0206-8862
Generic name: TAZOBACTAM SODIUM and PIPERACILLIN SODIUM
Labeler / Manufacturer: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 19980301

FDA application: NDA050750

## Active ingredients

- PIPERACILLIN SODIUM: 4 g/100mL
- TAZOBACTAM SODIUM: 500 mg/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0206-8862"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0206-8862
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ab9d90d-2f7f-4599-a44f-3d0a8f8ab623